(Press-News.org) Contact information: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston
Scientists improve human self-control through electrical brain stimulation
If you have ever said or done the wrong thing at the wrong time, you should read this. Neuroscientists at The University of Texas Health Science Center at Houston (UTHealth) and the University of California, San Diego, have successfully demonstrated a technique to enhance a form of self-control through a novel form of brain stimulation.
Study participants were asked to perform a simple behavioral task that required the braking/slowing of action – inhibition – in the brain. In each participant, the researchers first identified the specific location for this brake in the prefrontal region of the brain. Next, they increased activity in this brain region using stimulation with brief and imperceptible electrical charges. This led to increased braking – a form of enhanced self-control.
This proof-of-principle study appears in the Dec. 11 issue of The Journal of Neuroscience and its methods may one day be useful for treating attention deficit hyperactivity disorder (ADHD), Tourette's syndrome and other severe disorders of self-control.
"There is a circuit in the brain for inhibiting or braking responses," said Nitin Tandon, M.D., the study's senior author and associate professor in The Vivian L. Smith Department of Neurosurgery at the UTHealth Medical School. "We believe we are the first to show that we can enhance this braking system with brain stimulation."
A computer stimulated the prefrontal cortex exactly when braking was needed. This was done using electrodes implanted directly on the brain surface.
When the test was repeated with stimulation of a brain region outside the prefrontal cortex, there was no effect on behavior, showing the effect to be specific to the prefrontal braking system.
This was a double-blind study, meaning that participants and scientists did not know when or where the charges were being administered.
The method of electrical stimulation was novel in that it apparently enhanced prefrontal function, whereas other human brain stimulation studies mostly disrupt normal brain activity. This is the first published human study to enhance prefrontal lobe function using direct electrical stimulation, the researchers report.
The study involved four volunteers with epilepsy who agreed to participate while being monitored for seizures at the Mischer Neuroscience Institute at Memorial Hermann-Texas Medical Center (TMC). Stimulation enhanced braking in all four participants.
Tandon has been working on self-control research with researchers at the University of California, San Diego, for five years. "Our daily life is full of occasions when one must inhibit responses. For example, one must stop speaking when it's inappropriate to the social context and stop oneself from reaching for extra candy," said Tandon, who is a neurosurgeon with the Mischer Neuroscience Institute at Memorial Hermann-TMC.
The researchers are quick to point out that while their results are promising, they do not yet point to the ability to improve self-control in general. In particular, this study does not show that direct electrical stimulation is a realistic option for treating human self-control disorders such as obsessive-compulsive disorder, Tourette's syndrome and borderline personality disorder. Notably, direct electrical stimulation requires an invasive surgical procedure, which is now used only for the localization and treatment of severe epilepsy.
INFORMATION:
The study's co-lead authors are Jan R. Wessel, Ph.D., of the Department of Psychology at the University of California, San Diego; and Christopher R. Conner, student at the UTHealth Medical School. The fourth author is Adam Aron, Ph.D., at the University of California, San Diego.
The study is titled "Chronometric Electrical Stimulation of Right Inferior Frontal Cortex Increases Motor Braking." Authors received support from the National Institutes of Health Center for Clinical and Translational Sciences (KL2RR0224149), the Mischer Neuroscience Institute at Memorial Hermann-TMC and the Keck Center of the Gulf Coast Consortia.
Scientists improve human self-control through electrical brain stimulation
2013-12-13
ELSE PRESS RELEASES FROM THIS DATE:
UCLA stem cell scientists first to track joint cartilage development in humans
2013-12-13
UCLA stem cell scientists first to track joint cartilage development in humans
Stem cell researchers from UCLA have published the first study to identify the origin cells and track the early development of human articular cartilage, providing what ...
Researchers hope newly discovered gene interaction could lead to novel cancer therapies
2013-12-13
Researchers hope newly discovered gene interaction could lead to novel cancer therapies
Scientists from Virginia Commonwealth University Massey Cancer Center have revealed how two genes interact to kill a wide range of cancer cells. Originally discovered ...
Changing chemo not beneficial for metastatic B.C. patients with elevated circulating tumor cells
2013-12-13
Changing chemo not beneficial for metastatic B.C. patients with elevated circulating tumor cells
SAN ANTONIO — For women with metastatic breast cancer who had elevated amounts of circulating tumor cells (CTCs) in their blood after a first line ...
New presurgery combination therapy may improve outcomes for women with triple-negative breast cancer
2013-12-13
New presurgery combination therapy may improve outcomes for women with triple-negative breast cancer
SAN ANTONIO — The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete ...
New combination therapy fails to delay progression of advanced breast cancer
2013-12-13
New combination therapy fails to delay progression of advanced breast cancer
SAN ANTONIO — Adding the antibody therapy ramucirumab to the chemotherapy drug docetaxel did not delay disease progression for patients with HER2-negative, advanced ...
Bisphosphonate treatment fails to improve outcomes for women with chemoresistant breast cancer
2013-12-13
Bisphosphonate treatment fails to improve outcomes for women with chemoresistant breast cancer
SAN ANTONIO — Treatment with the bisphosphonate zoledronate did not improve outcomes for women with chemoresistant breast cancer, according to initial ...
New presurgery treatment combination more effective for women with triple-negative breast cancer
2013-12-13
New presurgery treatment combination more effective for women with triple-negative breast cancer
SAN ANTONIO — Adding the chemotherapy drug carboplatin and/or the antibody therapy bevacizumab to standard presurgery chemotherapy increased the ...
Additional drug shows promise for women with triple-negative breast cancer
2013-12-13
Additional drug shows promise for women with triple-negative breast cancer
SAN ANTONIO— In a nationwide study of women with "triple-negative" breast cancer, adding the chemotherapy drug carboplatin or the angiogenesis inhibitor Avastin to standard chemotherapy ...
Study shows new paradigm in breast cancer research
2013-12-13
Study shows new paradigm in breast cancer research
Promising drugs put on fast track
MAYWOOD, Ill. – The first investigator results from an unprecedented nationwide effort to test promising new breast cancer drugs before the tumor is removed were presented during ...
True story: Not everyone lies frequently
2013-12-13
True story: Not everyone lies frequently
Many liars prove honest in their dishonesty
Washington, DC (December 10, 2013) – Does everybody lie? We are taught that this is common sense and that most people tell little white lies. But perhaps this isn't ...